Difamilast — Active Pharmaceutical Ingredient

Difamilast is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: OINTMENT. Routes: TOPICAL.

This content is for informational purposes only. Always consult a healthcare professional.

Difamilast (1 brand name, 1 dosage form, 1 route)

Available dosage forms: OINTMENT.

Routes of administration: TOPICAL.

Brand Names

  • ADQUEY

Indications and Usage

ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis.

Dosage and Administration

ADQUEY is for topical use only and not for ophthalmic, oral, or intravaginal use. Apply a thin layer of ADQUEY twice daily to affected areas and rub in completely. Wash hands after application. Avoid areas of the skin that are infected when applying ADQUEY.

Contraindications

None.

Mechanism of Action

Difamilast is an inhibitor of phosphodiesterase-4 (PDE-4). Difamilast’s inhibition of PDE-4 (a major cyclic adenosine monophosphate (AMP)-metabolizing enzyme) activity leads to accumulation of intracellular cyclic AMP and decreased productions of various cytokines and chemokines. However, the specific mechanism(s) by which difamilast exerts its therapeutic action is not well defined.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.